3 completed, 1 not yet recruiting, 1 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 3, Not yet recruiting 1, Terminated 1 |
Follow SOC: new trials by email Literature Review of SOC trials Research Report on SOC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia inclisiran, SOC - Acute Coronary Syndrome | Phase 4 | Not yet recruiting | Novartis Pharmaceuticals | 300 | 2026-10-31 | 2026-10-30 |
| Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers Amnion-Intermediate-Chorion, Amnion-Chorion-Amnion, Standard of Care - Diabetic Foot Ulcer, Venous Leg Ulcer | Phase 4 | Completed | Cellution Biologics | 292 | 2024-10-14 | 2026-04-13 |
| Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study Sodium Zirconium Cyclosilicate (SZC), Local standard of care - Hyperkalaemia, Chronic Kidney Disease | Phase 4 | Completed | AstraZeneca | 186 | 2022-03-24 | 2025-11-28 |
| Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron Injectafer, SOC - Iron Deficiency Anemia (IDA) | Phase 4 | Completed | American Regent, Inc. | 1025 | 2013-08-15 | 2025-05-22 |
| Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease Implantable Cardiac Monitor, Standard of Care - Chagas Disease, Heart Diseases | Phase 4 | Terminated | Medtronic Cardiac Rhythm and Heart Failure | 12 | 2013-07-01 | 2016-10-12 |
Acute Coronary Syndrome (1) · Anemia, Iron-Deficiency (1) · Chagas Disease (1) · Diabetic Foot (1) · Heart Diseases (1) · Hyperkalemia (1) · Hyperlipidemias (1) · Renal Insufficiency, Chronic (1) · Ulcer (1) · Varicose Ulcer (1)
American Regent, Inc. (1) · AstraZeneca (1) · Cellution Biologics (1) · Medtronic Cardiac Rhythm and Heart Failure (1) · Novartis Pharmaceuticals (1)
Argentina (1) · Belgium (1) · Colombia (1) · France (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)
Claudio Muratore, MD (1) · Diego Venagas, MD (1) · Jose Carlos Pachon Mateos, MD (1) · Luis Medesani, MD (1) · Mark Falone, MD (1)